ImportRefusal LogoImportRefusal

NEFTIS LABORATORIOS SL

⚠️ Moderate Risk

FEI: 3021499529 • Santa Eulalia de Ron��ana, Barcelona • SPAIN

FEI

FEI Number

3021499529

📍

Location

Santa Eulalia de Ron��ana, Barcelona

🇪🇸

Country

SPAIN
🏢

Address

C/ Roquetes Nave 94 P.I. Can Magre, , Santa Eulalia de Ron��ana, Barcelona, Spain

Moderate Risk

FDA Import Risk Assessment

36.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

12
Total Refusals
6
Unique Violations
12/3/2019
Latest Refusal
12/13/2013
Earliest Refusal

Score Breakdown

Violation Severity
55.0×40%
Refusal Volume
41.3×30%
Recency
0.0×20%
Frequency
20.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

1610×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

328010×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

33310×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

7510×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3242×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

Refusal History

DateProductViolationsDivision
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2019
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/13/2013
54YBL02CARNITINE, VIT/MIN/PROTEIN/UNCONVENTIONAL DIETARY SPEC FOR HUMAN/ANIMAL, N.E.C.)
324NO ENGLISH
New York District Office (NYK-DO)
12/13/2013
54YCL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
324NO ENGLISH
New York District Office (NYK-DO)

Frequently Asked Questions

What is NEFTIS LABORATORIOS SL's FDA import refusal history?

NEFTIS LABORATORIOS SL (FEI: 3021499529) has 12 FDA import refusal record(s) in our database, spanning from 12/13/2013 to 12/3/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NEFTIS LABORATORIOS SL's FEI number is 3021499529.

What types of violations has NEFTIS LABORATORIOS SL received?

NEFTIS LABORATORIOS SL has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about NEFTIS LABORATORIOS SL come from?

All FDA import refusal data for NEFTIS LABORATORIOS SL is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.